Therefore, exploring multiple markers associated with CRC prognosis and treatment, in addition to generic single neutrophil markers (e.g. CD66b), could reveal novel neutrophil subtypes in the CRC. The gene discussed is CEACAM8; the disease is colorectal carcinoma.